Laterally Extending Platform Microelectrode Reducing Tissue Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable microelectrodes face significant challenges due to tissue encapsulation, which leads to decreased sensitivity and efficacy over time, limiting their use in neuroscience and prosthetic applications, particularly in spinal cord injuries and limb amputations.
Innovation Solution
The design of an implantable microelectrode with a laterally extending platform of subcellular dimensions, featuring a backbone portion and radially projecting ribs, reduces tissue encapsulation by minimizing the surface area in contact with biological tissue and creating an open architecture, thereby improving long-term performance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a conventional microelectrode design with solid shank is used, then structural strength is maintained, but tissue encapsulation increases and electrode sensitivity decreases over time
Solution Approach 1:
The microelectrode shank incorporates a porous or lattice structure instead of a solid construction, allowing tissue ingrowth through the porous walls while maintaining structural integrity. This reduces the foreign body response and minimizes encapsulation, thereby preserving electrode sensitivity and recording quality over long-term implantation.
Solution Approach 2:
The shank is divided into multiple segments or struts forming a lattice structure, creating open spaces between structural elements. This segmentation reduces the continuous surface area that triggers encapsulation while maintaining mechanical strength through the distributed framework, improving long-term electrode performance.
2Object-affected harmful factors
If the microelectrode shank surface area is reduced to minimize encapsulation, then tissue encapsulation decreases, but mechanical strength may be compromised
Solution Approach 1:
The shank is segmented into multiple load-bearing struts arranged in a lattice pattern, distributing mechanical stresses across multiple elements rather than relying on a continuous solid structure. This segmentation maintains structural strength while reducing the total surface area in contact with tissue, thereby minimizing encapsulation.
Solution Approach 2:
The shank combines materials with different properties to achieve both strength and reduced encapsulation. The lattice structure may use high-strength materials for the struts while incorporating biocompatible coatings or porous sections that reduce tissue adhesion, creating a composite structure that balances mechanical requirements with biocompatibility.
3Reliability
If a laterally extending platform with open architecture is implemented, then tissue encapsulation is reduced and signal quality is maintained, but device complexity increases
Solution Approach 1:
The platform is segmented into a lattice of struts rather than a solid continuous structure, creating open spaces that reduce tissue encapsulation. This segmented approach maintains signal quality by preserving access to neural tissue while the modular lattice design allows for standardized manufacturing processes, mitigating the increase in device complexity.
Solution Approach 2:
The design transitions from a two-dimensional planar platform to a three-dimensional lattice structure with vertical struts and open spaces. This dimensional change creates pathways for tissue access while maintaining platform functionality, and the repeating geometric patterns in three dimensions can be manufactured using additive or stereolithography processes that simplify complex structure production.
Data Source
AI summary
In some embodiments, an implantable microelectrode is provided with a shank comprised of a laterally extending platform whose thickness and/or configuration contributes to reduced tissue encapsulation, with at least one electrode site disposed at least partially on or in the laterally extending platform. Novel methods of designing, making, and using an implantable microelectrode or biosensor resulting in reduced tissue encapsulation are also disclosed.